1379666-56-4

Basic information

• Product Name: N-(4-chloro-2-fluoro-3-formylphenyl)acetamide
• Synonyms: N-(4-chloro-2-fluoro-3-formylphenyl)acetamide
• CAS NO: 1379666-56-4
• Molecular Weight: 215.611
• Mol File: 1379666-56-4.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: N-(4-chloro-2-fluoro-3-formylphenyl)acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(4-chloro-2-fluoro-3-formylphenyl)acetamide(1379666-56-4)
• EPA Substance Registry System: N-(4-chloro-2-fluoro-3-formylphenyl)acetamide(1379666-56-4)

Safety Data

• Hazardous Substances Data: 1379666-56-4(Hazardous Substances Data)

Upstream product

• 59280-70-5 4'-chloro-2'-fluoroacetanilide 
• 68-12-2 N,N-dimethyl-formamide 
• 57946-56-2 2-fluoro-4-chloroaniline 

Downstream Products

• 1442470-80-5 N-(4-chloro-2-fluoro-3-(hydroxymethyl)phenyl)acetamide 
• 1442470-82-7 3-acetamido-6-chloro-2-fluorobenzyl methanesulfonate 
• 1442470-84-9 N-(4-chloro-3-(cyanomethyl)-2-fluorophenyl)acetamide 
• 1442470-86-1 ethyl 2-(3-amino-6-chloro-2-fluorophenyl)acetate 
• 1442470-88-3 3-(3-amino-6-chloro-2-fluorophenyl)-7-chloro-1-ethyl-1,6-naphthyridin-2(1H)-one 
• 1442470-89-4 3-(3-amino-6-chloro-2-fluorophenyl)-1-ethyl-7-(methylamino)-1,6-naphthyridin-2(1H)-one 
• 1442472-19-6 1-(4-chloro-3-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea 
• 1379666-62-2 2-(benzyl(4-fluoro-1-oxo-2,3-dihydro-1H-inden-5-yl)amino)-N,N-diethylacetamide 
• 1379666-61-1 5-(benzylamino)-4-fluoro-2,3-dihydro-1H-inden-1-one 
• 1379666-59-7 3-(3-acetamido-2-fluorophenyl)propanoic acid 
• 1379666-58-6 (E)-3-(3-acetamido-6-chloro-2-fluorophenyl)acrylic acid 

Relevant articles and documents

Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases

The invention relates to dihydronaphthyridines and related compounds; compositions comprising an effective amount of a dihydronaphthyridine or a related compound; and methods for treating or preventing proliferative diseases comprising the administration of an effective amount of a dihydronaphthyridine or a related compound.

NOVEL COMPOUND, AND KINESIN SPINDLE PROTEIN INHIBITOR AND APPLICATION THEREOF

A compound represented by the following General Formula (I): where, in General Formula (I), R1 and R2 each represent an alkyl group which may have a substituent, R3 represents the following General Formula (II) or (III), and R1 and R2 may be identical or different, where, in General Formulas (II) and (III), X represents a hydrogen atom or a halogen atom, R4 represents a methyl group, a dimethyl group or an oxygen atom, and * represents a binding position.